# Filgrastim With or Without Plerixafor in Treating Patients With Multiple Myeloma Previously Treated With Lenalidomide

Source: https://onco.cc/trials/nct01301963/  
OnCo record `nct01301963` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 3 trial of Plerixafor and Filgrastim in Multiple myeloma, run by Case Comprehensive Cancer Center, recorded as terminated on the registry.

## Summary

Filgrastim With or Without Plerixafor in Treating Patients With Multiple Myeloma Previously Treated With Lenalidomide is a phase 3 interventional study registered as NCT01301963 by Case Comprehensive Cancer Center, with 9 participants recorded, started 2011-07 and due to reach its primary completion in 2013-06. Interventions recorded: plerixafor, filgrastim. Conditions recorded: Refractory Multiple Myeloma.

Linked to the drug Plerixafor because the registry names it among its interventions and Multiple myeloma among its conditions. Registry record only: no result has been read by an editor.

## Fields

- Kind: Trial
- Last checked: 2026-09-22
- Tags: pipeline; ctgov-ingest
- Registry id: NCT01301963
- Phase: 3
- Setting: Comparison of Plerixafor and G-CSF Versus G-CSF Alone for Stem Cell Mobilization in Patients With Multiple Myeloma Previously Treated With Lenalidomide
- Sponsor: Case Comprehensive Cancer Center
- Enrolled: 9

## Sources

- ClinicalTrials.gov NCT01301963: https://clinicaltrials.gov/study/NCT01301963

## Connected records

- cancers: [Multiple myeloma](https://onco.cc/cancers/multiple-myeloma/)
- drugs: [Filgrastim (G-CSF)](https://onco.cc/drugs/filgrastim/), [Plerixafor](https://onco.cc/drugs/plerixafor/)

---
JSON: https://onco.cc/api/v1/entities/nct01301963.json